Early Warning—How a Simple Blood Draw May Predict IPF Survival
Researchers at Stanford University School of Medicine have shown that immune cells from a blood sample are linked to worse outcomes in IPF....
What Americans Should Know About Treatment with Esbriet® (Pirfenidone) for IPF
Get the facts on one of two common IPF treatments with the Pulmonary Fibrosis Foundation’s new Fact Sheet Series....
Stopping and Reversing IPF—Promedior’s Push for a Cure
In a recent podcast, Promedior CEO Jason Lettmann was interviewed about PRM-151, his company’s experimental drug treatment for IPF and other scarring diseases....